| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis
|
Ghalie, R G
|
|
2002
|
8 |
5 |
p. 441-445
|
artikel
|
| 2 |
Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue
|
Kalkers, N F
|
|
2002
|
8 |
5 |
p. 410-414
|
artikel
|
| 3 |
CADASIL imitating multiple sclerosis: the importance of MRI markers
|
O'Riordan, S
|
|
2002
|
8 |
5 |
p. 430-432
|
artikel
|
| 4 |
Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone
|
Hoogervorst, E LJ
|
|
2002
|
8 |
5 |
p. 415-419
|
artikel
|
| 5 |
Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis
|
Hao, Q
|
|
2002
|
8 |
5 |
p. 436-440
|
artikel
|
| 6 |
Cytokines in multiple sclerosis: methodological aspects and pathogenic implications
|
Özenci, V
|
|
2002
|
8 |
5 |
p. 396-404
|
artikel
|
| 7 |
Developing clinical outcome measures in multiple sclerosis: an evolving process
|
Thompson, Alan J
|
|
2002
|
8 |
5 |
p. 357-358
|
artikel
|
| 8 |
Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences
|
Leigh, R
|
|
2002
|
8 |
5 |
p. 420-429
|
artikel
|
| 9 |
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
|
Martínez-Cáceres, E M
|
|
2002
|
8 |
5 |
p. 390-395
|
artikel
|
| 10 |
Multiple sclerosis functional composite: impact of reference population and interpretation of changes
|
Uitdehaag, B MJ
|
|
2002
|
8 |
5 |
p. 366-371
|
artikel
|
| 11 |
Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy
|
|
|
2002
|
8 |
5 |
p. 405-409
|
artikel
|
| 12 |
Quality of life in multiple sclerosis: influence of interferon-β1a (Avonex®) treatment
|
Vermersch, P
|
|
2002
|
8 |
5 |
p. 377-381
|
artikel
|
| 13 |
Technical note: the comparison of hypointense lesions from ‘pseudo-T1’ and T1-weighted images in secondary progressive multiple sclerosis
|
Hickman, S J
|
|
2002
|
8 |
5 |
p. 433-435
|
artikel
|
| 14 |
The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials
|
Rudick, R A
|
|
2002
|
8 |
5 |
p. 359-365
|
artikel
|
| 15 |
The reliability and validity of the Nottingham Extended Activities of Daily Living Scale in patients with multiple sclerosis
|
Nicholl, C R
|
|
2002
|
8 |
5 |
p. 372-376
|
artikel
|
| 16 |
Three screening batteries to detect cognitive impairment in multiple sclerosis
|
Aupperle, R L
|
|
2002
|
8 |
5 |
p. 382-389
|
artikel
|
Tijdschrift beschrijving